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Abstract Ceramides are reported to stimulate different effector
systems, among them atypical protein kinases C (PKCs). When
HEK 293 cells, stably expressing adenylyl cyclase type II (AC
II), were treated with various ceramide derivatives, adenylyl
cyclase activity was enhanced 8^15-fold. The stimulation by the
most potent analog, C18/C24 ceramide, was comparable to that
by the phorbolester TPA. The stimulatory effect of ceramide was
not restricted to AC II, although the type I and type V enzymes
were affected less dramatically. Unexpectedly, the dihydro
derivatives of ceramides, generally serving as non-activating
controls, exhibited only slightly lower stimulation than cera-
mides, whereas short-chain ceramides (e.g. C2) were without
effect. The action of ceramides was at least partially inhibited by
okadaic acid, suggesting involvement of a phosphatase. Further-
more, ceramides and TPA operated synergistically. While the
PKC inhibitor staurosporine counteracted the action of phorbol-
esters, it significantly (2.5U) enhanced the effect of ceramides.
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1. Introduction
Adenylyl cyclases from higher organisms are regulated by
phosphorylation as a consequence of crosstalk with other sig-
naling pathways [1^5]. These generate second messengers
which stimulate protein kinase C (PKC). While the second
messenger diacylglycerol activates classical and novel PKC
subforms, the recently emerged second messenger ceramide
is one of the stimulators of atypical PKCs. Ceramide is gen-
erated from sphingomyelin (e.g. via TNF-K), which through
activation of a cytosolic phospholipase A (cPLA) and libera-
tion of arachidonic acid [6] regulates neutral or acidic sphin-
gomyelinases (Smases). The latter in turn release ceramide
from the plasma membrane or from intracellular compart-
ments. The targets of ceramide have not been fully elucidated,
but among them are a membrane-associated protein kinase, a
cytosolic protein phosphatase 2A and the j-isoform of PKC
[7^9].
We have recently shown that adenylyl cyclase type II (AC
II) is a preferred target of phorbolester-stimulated PKC and
have presented evidence by site-directed mutagenesis that Thr-
1057 is the phosphoryl acceptor particularly involved in sensi-
tization via phorbolester-stimulated PKCs. However, stimula-
tion by ceramide as a potential activator of atypical PKCs
was not a¡ected by this mutation [10,11].
Here we show that other adenylyl cyclase subtypes besides
AC II, namely AC I and AC V, stably expressed in HEK 293
cells, are also directly or indirectly targets of a ceramide-de-
pendent event, leading to enhanced enzymatic activity. Since
dihydroceramides were qualitatively similarly e¡ective, the
underlying mechanism seems to di¡er from the classical cer-
amide action. The site of the ceramide-induced modi¢cation,
resulting in activation of the catalyst, is not known yet. How-
ever, the fact that the e¡ect was prevented by okadaic acid
and enhanced by staurosporine argues for a phosphatase
being involved.
2. Materials and methods
2.1. Materials
C18/C24 ceramide (type III), C16 dihydroceramide, TPA, isobutyl-
methylxanthine, adenosine-5P-triphosphate were obtained from Sigma.
C2 ceramide and C2 dihydroceramide were from Biomol. Fetal calf
serum, 5P-cyclic AMP, DNase I, DOSPER and alkaline phospha-
tase (molecular biology grade) were purchased from Boehringer
(Mannheim). Minimum essential medium (MEM) and G-418 were
from Gibco and Boehringer, Ingelheim respectively. [K-32P]ATP,
[3H]adenine and okadaic acid were obtained from ICN; C16 ceramide
and staurosporine were purchased from Calbiochem.
2.2. Stable transfection of HEK 293 cells
HEK 293 cells were grown at 37‡C in MEM supplemented with
10% fetal bovine serum in a humidi¢ed 95% air/5% CO2 incubator.
2.2.1. AC I. A HindIII-XbaI fragment from bovine brain type I
adenylyl cyclase [12] was subcloned from pSK-ACI into SmaI-re-
stricted pXMD1 [13] via blunt-end ligation. Thereafter the type I
cDNA was excised from pXMD-ACIrev with EcoRI and SalI, inserted
into EcoRI-XhoI-restricted pcDNA3 and used for transfection of
HEK 293 cells by the calcium phosphate method. Neomycin-resistant
cells were selected in culture medium containing G-418 (500 Wg/ml).
2.2.2. AC II. The full length cDNA for rat type II adenylyl cy-
clase [14] was excised from pBluescript with EcoRI, introduced into
pXMD1 and, together with pRSV neo, used for transfection of HEK
293 cells by the calcium phosphate method. Neomycin-resistant cells
were selected in culture medium containing G-418 (400 Wg/ml).
2.2.3. AC V. The full length cDNA for type V adenylyl cyclase
from rabbit myocardium [15] was excised from pXMD-AC V with
KpnI and XhoI, introduced into pcDNA3 and used for transfection of
HEK 293 cells by lipofection with DOSPER. Neomycin-resistant cells
were selected in culture medium containing G-418 (500 Wg/ml).
2.3. Measurement of AC activity following [3H]adenine labeling
The assay was performed according to Salomon [16] and Avidor-
Reiss et al. [17]. Stably transfected HEK 293 cells (2.2U105) were ¢rst
incubated for 5 h at 37‡C with ceramide and dihydroceramide deriv-
atives or vehicle (see ¢gure legends) in a total volume of 500 Wl and
treated with the phosphodiesterase inhibitor 1-methyl-3-isobutylxan-
thine (1 mM) for 10 min. The cells were then loaded with 2 WCi
[3H]adenine for 60 min, followed by the addition of adenylyl cyclase
stimulators. The reaction was terminated with 1/6 volume of 30%
TCA, 10 mM cAMP, 10 mM ATP, 5000 cpm [32P]cAMP and 5000
cpm [32P]ATP as internal standards.
Adenylyl cyclase activity was calculated according to Salomon [16]
as follows:
% conversion  cAMPbuiltU100cAMPbuilt ATPbuilt:
2.4. Membrane preparation
Cells were lysed by freeze/thaw in 10 mM Tris bu¡er, pH 7.4, 1 mM
EDTA, 0.5 mM DTT, 0.5 mM PMSF, 3.2 Wg/ml TPCK, 22 Wg/ml
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TLCK, 3.2 Wg/ml soybean trypsin inhibitor, 2.8 Wg/ml Trasylol, 1 mM
benzamidine, 0.1 mM benzethonium chloride, 10 mM NaF and 1 mM
Na3VO4. Membranes were prepared by di¡erential centrifugation and
stored in the above bu¡er supplemented with 10% glycerol at 380‡C.
2.5. Miscellaneous
Polyacrylamide gel electrophoresis (5^15% acrylamide) according to
Laemmli [18] and immunoblotting were conducted as described pre-
viously [19]. Monoclonal antibody BBC-2, labeled with alkaline phos-
phatase (BBC-2-AP), was used for detection by chemiluminescence
with CSPD as substrate [20]. Alkaline phosphatase was coupled to
antibody according to the speci¢cations of the distributor.
3. Results and discussion
Fig. 1 shows a time course of the naturally occurring cer-
amide derivative from bovine brain (a mixture of C18 and C24
ceramides) in£uencing the basal activity of AC II stably ex-
pressed in HEK 293 cells. Ceramides were suspended in aque-
ous bu¡er by dilution of a solution in ethanol/dodecane (98:2)
to a ¢nal concentration of 1% following a suggestion of Li et
al. [21]. Maximal stimulation was obtained after 6 h (15-fold),
while prolonged treatment resulted in decline of activity,
probably due to cell death.
Fig. 2 demonstrates the e¡ect of C18/C24 ceramide on sev-
eral representatives of adenylyl cyclase subtype families stably
expressed in HEK 293 cells : AC I (Ca2/CaM-stimulated,
inhibited by LQ subunits), AC II (conditionally stimulated by
LQ subunits in concert with Ks) and AC V (a member of the
Ca2-inhibitable subfamily) and the HEK 293 endogenous
enzymes as control were tested for the lipid’s e¡ect on basal
and forskolin-stimulated activity. As can be seen from the
inset, all subforms were readily expressed. The largest e¡ect
of ceramide could be observed with AC II, the non-stimulated
activity of which was enhanced 8^15-fold, while that of AC I
and AC V was only doubled. Besides basal activity, stimula-
tion by forskolin was also a¡ected. Although with AC II
forskolin stimulation was still three times higher than in con-
trol cells, the action of the diterpene may be more precisely
seen as inhibition of non-stimulated activity. Although not
inhibited by forskolin as shown for AC II, ceramide-treated
HEK 293 cells expressing AC I or AC V were signi¢cantly less
stimulated by forskolin (40^70%) than their untreated con-
trols. As an example, for AC V, the ratio of activities in the
presence and absence of forskolin dropped from 27.5 to 5.5
after ceramide treatment.
In contrast to stimulation by forskolin, that by 1035 M
isoproterenol was still present in cells expressing AC II pre-
viously treated with ceramide (1.6-fold, not shown). The loss
of forskolin stimulation of AC II on treatment with C18/C24
ceramide was in contrast to that on treatment with phorbol-
esters as forskolin was still a potent activator in TPA-stimu-
lated cells (see also Fig. 4). All e¡ects of ceramide on AC II
(enhanced basal activity, reduced stimulation with forskolin)
were also observed with HEK 293 cells expressing the cyclase
transiently, as reported previously [11]. For obvious reasons,
AC II was the object of the following studies.
In Fig. 3 a dose-response curve of various ceramide deriv-
atives and the e¡ect on non-stimulated activity of AC II is
shown. It is evident that the mixture of C18 and C24 ceramides
was most e⁄cient, while the C16 derivative was about half as
e¡ective and the acetyl derivative was stimulating only at
concentrations s 20 WM. Most remarkable, however, was
the fact that the dihydro derivatives of ceramides, otherwise
known as inactive controls, were almost as e¡ective (60^80%)
as their unsaturated counterparts. The following studies in
this paper were conducted with the most potent C18/C24 cer-
amide derivative mixture.
Of further importance was the ¢nding that ceramide and
the phorbolester TPA activated synergistically (Fig. 4) at least
in the absence of forskolin or other cyclase stimulators.
Next we wanted to investigate whether the e¡ect of C18/C24
ceramide on AC II was due to stimulation of a protein kinase
C. In the absence of C18/C24 ceramide, the potent PKC inhib-
itor staurosporine led to a modest enhancement of basal and a
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Fig. 1. Time course of C18/C24 ceramide-stimulated HEK 293 AC II
activity. HEK 293 AC II cells (see Section 2) were incubated with
C18/C24 ceramide (20 WM) or ethanol:dodecane (98:2) as control (¢-
nal concentration 1%) for the indicated times and then labeled with
[3H]adenine for 60 min. cAMP formation was measured after an-
other 10 min as described in Section 2. Values are given as dupli-
cates þ S.E.M.
Fig. 2. In£uence of C18/C24 ceramide on cells expressing other ad-
enylyl cyclase subtypes. HEK 293 cells were stably transfected with
cDNAs encoding adenylyl cyclase subtypes I, II and V as described
in Section 2. Cells were incubated with C18/C24 ceramide (20 WM)
or ethanol:dodecane (98:2) as control (¢nal concentration 1%) for
5 h, labeled with [3H]adenine for 60 min and stimulated with and
without forskolin (10 WM; 10 min). cAMP formation was measured
as described in Section 2. Values are given as duplicates þ S.E.M.
Inset: Western blot analysis of AC subtypes I, II and V. Mem-
branes from HEK 293 cells (WT 25 Wg) or from HEK 293 cells sta-
bly transfected with AC I (25 Wg), AC II (50 Wg) or AC V (200 Wg)
were separated by SDS-PAGE, blotted onto Immobilon P mem-
brane and visualized by antibody BBC-2-AP and chemiluminescence
as described in Section 2. The bands in the lower molecular weight
range (AC I) are probably due to proteolysis.
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more pronounced enhancement (3-fold) of forskolin-stimu-
lated activity (Fig. 5A). Surprisingly, the activity induced by
ceramide was further potentiated (2.5^3.4-fold) by staurospor-
ine in the absence or presence of 10 WM forskolin (Fig. 5B).
As a control, we tested the e¡ect of staurosporine on TPA-
induced stimulation of adenylyl cyclase activity. As was to be
expected, staurosporine signi¢cantly counteracted the TPA
e¡ect both in the presence and in the absence of 10 WM for-
skolin (not shown). Although it has been reported that stau-
rosporine caused ceramide formation in neuronal cells [22],
this cannot explain the synergistic interaction between stau-
rosporine and ceramide shown here.
In contrast, as shown in the experiment in Fig. 6, the cer-
amide-induced activation was signi¢cantly inhibited by oka-
daic acid, known to have the highest a⁄nity for PP-2A phos-
phatases. The degree of inhibition by okadaic acid was
variable, ranging from 40% to 70%. Thus the in£uence of
ceramide was at least partially explained by its activation of
a protein phosphatase. As was to be expected, the activation
by the phorbolester TPA was not a¡ected by 50 nM okadaic
acid (not shown).
Treatment of HEK 293 cells, overexpressing adenylyl cy-
clase subtypes, with ceramides had some quite remarkable
consequences especially on the type II subform. C16 and
more so C18/C24 ceramide led to a dramatic stimulation of
adenylyl cyclase activity, comparable or even superior to
that obtained with phorbolesters.
A peculiarity to be mentioned was that the dihydro deriv-
atives of ceramides, normally known as inactive controls, were
almost as e¡ective stimulators as the ceramides themselves,
and that short-chain ceramides (C2) were considerably less
potent than long-chain derivatives. Another unexpected, and
as yet unexplained, ¢nding was the signi¢cant inhibition of
adenylyl cyclase by the prominent stimulator forskolin in cer-
amide-treated HEK 293 AC II cells. Inhibitory e¡ects of for-
skolin at low concentrations have been previously observed
with GTPQS-pretreated platelet adenylyl cyclase [23] and with
hCG-stimulated Leydig cell adenylyl cyclase [24]. Although in
the latter system the e¡ect was prevented by pertussis toxin,
FEBS 19768 29-1-98
Fig. 5. Synergism between staurosporine and C18/C24 ceramide on
activation of AC II. HEK 293 AC II cells were preincubated with
staurosporine or DMSO as vehicle for 1 h and then treated with
ethanol:dodecane (98:2, 1%) (A) or 20 WM C18/C24 ceramide (B)
for 5 h, followed by labeling with [3H]adenine for 60 min. For esti-
mation of cAMP formation (see Section 2) cells were stimulated
with and without forskolin (10 min). Values are given as duplicates
þ S.E.M.
Fig. 4. Synergistic stimulation of AC II by C18/C24 ceramide and
phorbolester. HEK 293 AC II cells were incubated with C18/C24 cer-
amide (20 WM) or TPA (1 WM) or a combination of both. Incuba-
tion with ceramide was for 5 h, followed by [3H]adenine labeling
for 60 min and by treatment for 15 min with and without TPA.
cAMP formation in the absence or presence of 10 WM froskolin
was measured after 10 min as described in Section 2. Values are giv-
en as duplicates þ S.E.M. The vehicles for ceramide and for TPA
were ethanol:dodecane (98:2) (1%) and DMSO (0.1%) respectively.
They did not a¡ect cAMP formation. Basal and forskolin-stimulated
cells in the absence of ceramide or TPA showed 0.3% and 1.1%
conversion respectively.
Fig. 3. Stimulation of HEK 293 AC II by di¡erent ceramide and di-
hydroceramide derivatives. HEK 293 AC II cells were incubated
with various ceramide and dihydroceramide derivatives or ethanol:
dodecane (98:2) as control (¢nal concentration 1%) for 5 h and
then labeled with [3H]adenine for 60 min. cAMP formation was
measured after another 10 min incubation as described in Section 2.
Values are given as duplicates þ S.E.M.
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an explanation on a molecular basis could not be provided in
either case. E¡ects of ceramides on other adenylyl cyclase
subforms (I, V) were di¡erent. While basal activity was only
marginally a¡ected, stimulation by forskolin was signi¢cantly
reduced especially in the case of AC V.
Regarding other cellular aspects, phorbolesters and ceram-
ides normally counteract each other [25,26]. Yet, at least in
the adenylyl cyclase II system described here, both interacted
in a synergistic way (Fig. 4).
Further studies have to be designed to explore the exact
mechanism by which exogenous ceramide may activate ad-
enylyl cyclase, especially type II. Furthermore, in the light
of the non-canonical action of ceramide it has to be decided
whether ceramide itself or a metabolite is the activating spe-
cies. On the other hand, the target has to be identi¢ed which is
modi¢ed directly or indirectly by ceramide. There is evidence
that this may not be the adenylyl cyclase itself, since the e¡ect
of ceramide, while still demonstrable in permeabilized cells,
was completely lost when membranes were prepared from
treated cells (A. Boºsel, unpublished). Otherwise the putative
modi¢cation of the catalyst may be reversible and may not
withstand further fractionation of the lysed cell.
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Fig. 6. Partial inhibition of C18/C24 ceramide action on AC II by
okadaic acid. HEK 293 AC II cells were preincubated with okadaic
acid for 1 h. To investigate the e¡ect of C18/C24 ceramide, cells
were treated without and with 20 WM ceramide for 5 h, followed by
labeling with [3H]adenine. For estimation of cAMP formation (see
Section 2) cells were stimulated with and without 10 WM forskolin
(10 min). Values are given as duplicates þ S.E.M.
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